Postoperative Cognitive Dysfunction Completed Phase 2 Trials for Ketamine (DB01221)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02049411Ketamine and Changes of the Short Portable Mental Status QuestionnaireSupportive Care